Company press releases

Displaying 101 - 129 of 129 results
Released Company Title Industry Topic
15 Nov 2021
07:30 CET 		THERAVET TheraVet annonce des résultats de sécurité et d’efficacité positifs pour BIOCERA-VET® dans l’ostéosarcome du chien 20103015 Pharmaceuticals Other subject
15 Nov 2021
07:30 CET 		THERAVET TheraVet Announces Positive Safety and Efficacy Results for BIOCERA-VET® in Canine Osteosarcoma 20103015 Pharmaceuticals Other subject
09 Nov 2021
07:30 CET 		THERAVET TheraVet Announces the Signing of a Research Contract With Degroof Petercam 20103015 Pharmaceuticals Other subject
09 Nov 2021
07:30 CET 		THERAVET TheraVet annonce la signature d’un contrat de recherche avec Degroof Petercam 20103015 Pharmaceuticals Other subject
03 Nov 2021
07:30 CET 		THERAVET TheraVet Expands Its Bone Substitutes Product Line 20103015 Pharmaceuticals Other subject
03 Nov 2021
07:30 CET 		THERAVET TheraVet élargit sa gamme de substituts osseux 20103015 Pharmaceuticals Other subject
29 Oct 2021
19:00 CEST 		THERAVET TheraVet : Mise à disposition du rapport semestriel 2021 20103015 Pharmaceuticals Other subject
26 Oct 2021
17:45 CEST 		THERAVET TheraVet : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la loi du 02 mai 2007) 20103015 Pharmaceuticals Other subject
26 Oct 2021
07:30 CEST 		THERAVET TheraVet: First Patients Treated With BIOCERA-VET® Bone Surgery in the United States of America 20103015 Pharmaceuticals Other subject
26 Oct 2021
07:30 CEST 		THERAVET TheraVet : Premiers patients traités avec le substitut osseux BIOCERA-VET® aux États-Unis 20103015 Pharmaceuticals Other subject
21 Oct 2021
07:30 CEST 		THERAVET TheraVet : Lancement commercial de BIOCERA-VET® en France et aux Pays-Bas 20103015 Pharmaceuticals Other subject
21 Oct 2021
07:30 CEST 		THERAVET TheraVet: Commercial launch of BIOCERA-VET® in France and The Netherlands 20103015 Pharmaceuticals Other subject
07 Oct 2021
17:45 CEST 		THERAVET TheraVet apporte des précisions sur ses relations avec la société Graftys 20103015 Pharmaceuticals Other subject
22 Sep 2021
17:45 CEST 		THERAVET TheraVet annonce ses résultats financiers du 1er semestre 2021 et fait le point sur le développement de ses activités 20103015 Pharmaceuticals Other subject
22 Sep 2021
17:45 CEST 		THERAVET TheraVet Announces Its 2021 Half-year Results and Provides an Update on the Development of Its Activities 20103015 Pharmaceuticals Other subject
10 Sep 2021
07:30 CEST 		THERAVET TheraVet Announces the Launch of the Pivotal European Multicentric Clinical Study of VISCO-VET in Canine Osteoarthritis 20103015 Pharmaceuticals Other subject
10 Sep 2021
07:30 CEST 		THERAVET TheraVet annonce le lancement de l’étude clinique pivot multicentrique européenne évaluant VISCO-VET dans l’arthrose canine 20103015 Pharmaceuticals Other subject
08 Sep 2021
07:30 CEST 		THERAVET TheraVet Announces Positive Safety and Efficacy Results for VISCO-VET in Canine Osteoarthritis 20103015 Pharmaceuticals Other subject
08 Sep 2021
07:30 CEST 		THERAVET TheraVet annonce des résultats de sécurité et d’efficacité positifs pour VISCO-VET dans l’arthrose canine 20103015 Pharmaceuticals Other subject
01 Sep 2021
07:30 CEST 		THERAVET TheraVet annonce la nomination de Veerle Zonnekeyn comme Directrice des Affaires Réglementaires 20103015 Pharmaceuticals Other subject
01 Sep 2021
07:30 CEST 		THERAVET TheraVet Announces the Appointment of Veerle Zonnekeyn as Director of Regulatory Affairs 20103015 Pharmaceuticals Other subject
09 Aug 2021
17:45 CEST 		THERAVET TheraVet : Information relative au nombre total de droits de vote et d’actions composant le capital social 20103015 Pharmaceuticals Other subject
09 Aug 2021
17:45 CEST 		THERAVET TheraVet S.A.: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital 20103015 Pharmaceuticals Other subject
07 Jul 2021
07:30 CEST 		THERAVET TheraVet Provides Its Half-year Operational Update Of 2021 20103015 Pharmaceuticals Other subject
07 Jul 2021
07:30 CEST 		THERAVET TheraVet publie son point d’activité du 1er semestre 2021 20103015 Pharmaceuticals Other subject
02 Jul 2021
07:30 CEST 		THERAVET TheraVet élargit l’utilisation du BIOCERA-VET à une nouvelle approche curative de l’ostéosarcome du chien grâce à une prise en charge innovante et pluridisciplinaire 20103015 Pharmaceuticals Other subject
02 Jul 2021
07:30 CEST 		THERAVET TheraVet Extends the Use of BIOCERA-VET to a New Curative Approach of Osteosarcoma in Dogs Through an Innovative and Multidisciplinary Management 20103015 Pharmaceuticals Other subject
30 Jun 2021
07:30 CEST 		THERAVET TheraVet annonce son calendrier financier pour l’exercice 2021 20103015 Pharmaceuticals Other subject
30 Jun 2021
07:30 CEST 		THERAVET TheraVet Announces its 2021 Financial Calendar 20103015 Pharmaceuticals Other subject